![Ling Han](https://perspectives.agf.com/wp-content/uploads/Ling-Han-2023-AGF-Bio-Image-224x160-1.jpg)
Recent Articles from this contributor
![post image An Investor’s Guide to GLP-1 Drugs: Beyond Biopharma Stocks](https://perspectives.agf.com/wp-content/uploads/medtech-syringes-hp-hero-1920x720-1.jpg)
An Investor’s Guide to GLP-1 Drugs: Beyond Biopharma Stocks
In part one of a series, analyst Ling Han discusses the potential impact of GLP-1 drugs to healthcare stocks not directly involved in the development and manufacture of the medical world’s latest pharmaceutical phenomenon
![post image GLP-1: Healthcare’s Latest Investment Mega Theme](https://perspectives.agf.com/wp-content/uploads/health-care-video-glp1-drugs-hero-1920x567-1.jpg)
GLP-1: Healthcare’s Latest Investment Mega Theme
AGF analyst Ling Han discusses the pharmaceutical drug front and center with healthcare investors.